Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.77 USD | +2.82% | +4.67% | +48.49% |
Business Summary
Number of employees: 28
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jon Congleton
CEO | Chief Executive Officer | 60 | 20-10-31 |
Adam Levy
DFI | Director of Finance/CFO | 46 | 22-02-28 |
Jessica Ibbitson
CTO | Chief Tech/Sci/R&D Officer | - | 21-02-28 |
David Rodman
CTO | Chief Tech/Sci/R&D Officer | 69 | 20-12-31 |
Minji Kim
PRN | Corporate Officer/Principal | - | Jan. 03 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 56 | 21-01-31 | |
Glenn Sblendorio
BRD | Director/Board Member | 68 | 23-09-12 |
Daphne Karydas
BRD | Director/Board Member | 49 | 23-09-12 |
Olivier Litzka
BRD | Director/Board Member | 56 | 22-05-07 |
Jon Congleton
CEO | Chief Executive Officer | 60 | 20-10-31 |
Derek DiRocco
BRD | Director/Board Member | 43 | 22-05-07 |
BT Slingsby
FOU | Founder | 47 | 19-05-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 49,648,540 | 43,426,364 ( 87.47 %) | 0 | 87.47 % |
Company contact information
Mineralys Therapeutics, Inc.
150 North Radnor Chester Road Suite F200
19087, Radnor
+
http://www.mineralystx.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+48.49% | 634M | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- MLYS Stock
- Company Mineralys Therapeutics, Inc.